Evidence map›Paper›PMID 31921634›Full record

ReviewFrontiers in oncology2019

Role of Matrix Metalloproteinases in Angiogenesis and Cancer.

Saray Quintero-Fabián, Rodrigo Arreola, Enrique Becerril-Villanueva, Julio César Torres-Romero, Victor Arana-Argáez, Julio Lara-Riegos, Mario Alberto Ramírez-Camacho, María Elizbeth Alvarez-Sánchez

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 572 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
572citing papers in PubMed, 5 pooled it
33.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

572 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,005 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Pharmacological Insights intoMolecules (Basel, Switzerland) · 2026
    Review
  20. Article

512 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Saray Quintero-FabiánMultidisciplinary Research Laboratory, Military School of Graduate of Health, Mexico City, Mexico.
Rodrigo ArreolaPsychiatric Genetics Department, National Institute of Psychiatry "Ramón de la Fuente", Clinical Research Branch, Mexico City, Mexico.
Enrique Becerril-VillanuevaPsychoimmunology Laboratory, National Institute of Psychiatry "Ramón de la Fuente", Mexico City, Mexico.
Julio César Torres-RomeroBiochemistry and Molecular Genetics Laboratory, Facultad de Química de la Universidad Autónoma de Yucatán, Merida, Mexico.
Victor Arana-ArgáezPharmacology Laboratory, Facultad de Química de la Universidad Autónoma de Yucatán, Mérida, Mexico.
Julio Lara-RiegosBiochemistry and Molecular Genetics Laboratory, Facultad de Química de la Universidad Autónoma de Yucatán, Merida, Mexico.
Mario Alberto Ramírez-CamachoCentro de Información de Medicamentos, Facultad de Química de la Universidad Autónoma de Yucatán, Mérida, Mexico.
María Elizbeth Alvarez-SánchezGenomic Sciences Graduate Program, Universidad Autónoma de la Ciudad de Mexico, Mexico City, Mexico.
Autonomous University of Yucatán · MXInstituto Nacional de Psiquiatría · MXHospital Central Militar · MXUniversidad Autónoma de la Ciudad de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of metalloproteinases (TIMPs) downregulate the activity of these MMPs. Then, the angiogenic response can be directly or indirectly mediated by MMPs through the modulation of the balance between pro- and anti-angiogenic factors. This review analyzes recent knowledge on MMPs and their participation in angiogenesis.

Indexed as

angiogenesis and cancerimmune systemmetalloproteinasesMMPMT-MMP

Identifiers

PMID31921634
PMCPMC6915110
OpenAlexW2994405351

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.